Business
BioSpectrum Asia
Thyrocare announces appointment of Dr Ramesh Kinha as Chief Operating Officer
India-based Thyrocare Technologies has appointed Dr Ramesh Kinha as its Chief Operating Officer, further strengthening its leadership team as the company continues to scale its operations across India.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Indian S&T Minister Dr Jitendra Singh Honours Life Sciences Stalwarts With BioSpectrum India Excellence Awards 2025
The Union Minister of State (Independent Charge) Science & Technology, Dr Jitendra Singh, honoured the leading figures of the life sciences industry for their contributions and achievements for the year 2023-24 and 2024-25 during BioSpectrum India Excellence Awards 2025 event, organised by BioSpectrum India, an integrated B2B media platform for the bioscience industry, and MMA Spectrum Foundation, in New Delhi on December 5.
3 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
DHL Express enhances Asia Pacific leadership team with strategic appointments
Pharma logistics company DHL Express has made two key leadership appointments in Asia Pacific-Chee Choong Ng as Senior Vice President of Human Resources (HR) for Asia Pacific, and Samuel Lee as Managing Director for Taiwan.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
WHO and the European Commission expand partnership to combat AMR
The World Health Organization (WHO) and the European Commission's Health Emergency Preparedness Authority (HERA) have signed a €3.5 million agreement to expand their partnership to combat antimicrobial resistance (AMR) under the EU4Health programme.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Momentum in Motion: What Will Shape APAC's Life Sciences Landscape in 2026?
Asia-Pacific's life sciences sector is growing rapidly, driven by its scale, diversity and resilience. Accelerating demographic change and strong investment in innovation position the region to outpace global growth and shape the future of healthcare.
5 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Reshaping Asia's Healthcare with mRNA Innovation
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the biotechnology landscape across Asia and beyond. What emerged during this period was not just a breakthrough moment for mRNA, but the early foundation of a broader transformation that is still unfolding.
2 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Japan Pushes Startups to Power the Next Biotech Cycle
In recent years, the Japanese government has rolled out a series of initiatives to reshape the country's biopharma ecosystem. These include expanded venture funding, targeted subsidies for drug development, and tax incentives for investors, entrepreneurs, and startup employees.
4 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
PRISM BioLab partners with Talus Bioscience for AI-based drug discovery
Japan-based PRISM BioLab and US-based startup Talus Bioscience, Inc. have entered into a collaboration to discover novel inhibitors of transcription factor (TF) and protein-protein interaction (PPI) targets.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Ferronova raises $6 M to advance imageguided cancer surgery
Australian startup Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells and reduce the risk of undetected recurrence following surgery.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
PAHO launches roadmap to improve blood pressure control
The Pan American Health Organization (PAHO) has launched the new HEARTS Quality Framework, a practical guide published in The Lancet Regional Health - Americas, which countries can immediately use to enhance hypertension and cardiovascular risk management, prevent heart attacks and strokes, and deliver better care through primary health care within their communities.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
UK and Singapore launch new regulatory innovation corridor to fast-track health technologies
As part of this first-of-its-kind partnership between the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and Singapore's Health Sciences Authority (HSA), companies will have a coordinated fast track pathway to engage both regulators at the same time.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Zydus Lifesciences partners with Myriad Genetics to launch cancer-risk assessment diagnostic tests in India.
India-based Zydus Lifesciences has signed an agreement with US-based Myriad Genetics, a leader in molecular diagnostic testing and precision medicine.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Korea steps up pandemic response with $18.9 M investment in CEPI
The Republic of Korea has announced new $18.9 million support to bolster national and global efforts to protect against the next deadly pandemic and boost international health security.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Belgium and WHO sign new agreement to boost global health accessibility
The World Health Organization (WHO) has announced a new €8 million, four-year contribution from the Government of Belgium to accelerate global equitable access to essential health products and technologies.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Pharmacopoeia Commission of India inks 3 MoUs with Nagaland
The Pharmacopoeia Commission of India (IPC), an autonomous institute under the Ministry of Health and Family Welfare, Government of India, has signed three Memorandums of Understanding (MoUs) with Nagaland Medical Council, Nagaland State Drug Control Administration (NSDCA), Department of Health and Family Welfare, Nagaland and State Pharmacy Council, Government of Nagaland, a northeastern state of India.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
UK to prioritise medical graduates for training places
The UK government has put an offer to the British Medical Association (BMA) that would put in place emergency legislation for UK and Republic of Ireland medical graduates and doctors who have worked in the National Health Service (NHS) for a significant period of time to be prioritised for specialty training and tackling bottlenecks through an overhaul of recruitment for medical training.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Precious Medical Group invests RM500 M for advanced cancer care infrastructure in Malaysia
Singapore-based healthcare provider Precious Medical Group has announced the launch of the Tunku Laksamana Johor Cancer Centre and Hospital, a landmark RM500 million development featuring state-of-the-art diagnostic and treatment facilities.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Insilico Medicine, TaiGen collaborate for AIdriven PHD inhibitor for CKD-related anaemia
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company headquartered in Hong Kong, and Taiwan's TaiGen Biotechnology, a listed discoverybased and market-focused pharmaceutical company, as well as TaiGen Biopharmaceuticals, its wholly-owned Beijing subsidiary, have announced an exclusive pipeline out-licensing collaboration.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
WHO launches new cancer control planning course
In support of cancer control efforts in countries around the world, the WHO Academy has launched a course on National Cancer Control Planning for Programme Managers.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
The Future of mRNA Is Being Built in APAC
Beyond scientific advancement, mRNA represents a strategic opportunity shaped by policy stability, public investment and regional collaboration. Across APAC, governments are increasingly recognising that supportive regulatory frameworks and long-term funding can serve as powerful competitive advantages, attracting global capital and talent.
10 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
US FDA launches novel Digital Health Pilot to expand access to chronic disease technologies
The US Food and Drug Administration (FDA) has announced the TechnologyEnabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot, a voluntary pilot designed to promote access to certain digital health devices while safeguarding patient safety.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
University of Oxford launches world's first Phase II Nipah virus vaccine trial
The University of Oxford has launched the world's first Phase II clinical trial of a Nipah virus vaccine candidate.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
ASIA'S NEW GLOBAL PLAY IN PHARMA INNOVATION
The beginning of the new year has brought two notable developments from Asia's pharmaceutical landscape—one involving a government regulator and the other a private pharmaceutical major. While distinct in nature, both moves share a common strategic objective: stepping beyond regional boundaries to accelerate innovation and improve patient access to breakthrough therapies. One looks westward to Europe, the other to the United States.
2 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
CSL opens cell-based influenza vaccine and antivenom manufacturing facility in Melbourne
Australia's onshore vaccine manufacturing capabilities took a leap forward as Mark Butler MP, Minister for Health, Disability and Ageing, opened CSL Seqirus' state-of-the-art cell-based influenza vaccine and antivenom manufacturing facility in Melbourne.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Cambodia introduces lifesaving rotavirus vaccine nationwide
The Ministry of Health of the Kingdom of Cambodia has announced the nationwide introduction of the rotavirus vaccine into the National Immunisation Schedule, marking a significant milestone in protecting infants and young children from one of the leading causes of severe diarrhoea and child mortality.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
D3 Bio secures $108 M to advance global clinical programmes
D3 Bio, a global clinical-stage biotechnology company from China focused on the discovery and development of innovative oncology therapeutics, has announced the completion of a $108 million Series B financing round.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Rhinocare Korea accelerates global expansion with Singapore joint venture
Rhinocare Korea, a medtech innovator specialising in drug-free respiratory care, has announced plans to establish a joint venture (JV) in Singapore as part of its strategy to expand across Asia-Pacific, Europe, and North America.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Glenmark bags multi-regional rights of Hansoh Pharma's oncology drug for $1 B
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an exclusive license, collaboration and distribution agreement with Jiangsu Hansoh Pharmaceutical Group Co., for Aumolertinib, a third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) for the treatment of non-small cell lung cancer (NSCLC).
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
mRNA landscape in Japan
Japan's mRNA landscape is steadily evolving, shaped by domestic investment, active regulatory engagement, and growing alignment across industry, academia, and government to support both near-term scale-up and longer-term innovation.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Immutep inks oncology deal worth $349.5 M with Dr. Reddy's Laboratories
Australia-based Immutep Limited and Dr. Reddy's Laboratories, based in India, have announced that their respective wholly-owned subsidiaries, Immutep SAS and Dr. Reddy's Laboratories SA, have entered into a strategic collaboration and exclusive licensing agreement for the development and commercialisation of Eftilagimod Alfa (efti) in all countries outside North America, Europe, Japan, and Greater China.
1 min |